Rakin Kevin
- SEC CIK
- 0001184421
In the past year, 2 open-market purchase filings worth $100.2K and no sales.
Current role at each company
- ELUT Elutia Inc.Director, 10% Owneras of Jun 15, 2026
- QSI Quantum-Si IncDirectoras of May 20, 2026
- ORMP Oramed Pharmaceuticals Inc.Directoras of Mar 22, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $100.2K
- 2 filings
- Sold
- –
- 0 filings
- Net
- +$100.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Rakin Kevin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ELUT Elutia Inc.
Director, 10% Owner7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 2, 2026 (view filing)5:01 PM ET | Jan 30 | 3 days | Rakin Kevin and 3 othersDirector, 10% Owner | PPurchaseClass A Common Stock | +70.0K | $1.06 | +$74.2K | +55.5%196.1K after | |
| Dec 19, 2025 (view filing)4:59 PM ET | Dec 17 | 2 days | Rakin Kevin and 3 othersDirector, 10% Owner | PPurchaseClass A Common Stock | +50.0K | $0.5199 | +$26.0K | +18.4%322.4K after | |
| Mar 13, 2025 (view filing)4:28 PM ET | Feb 3 | 38 daysLate | Rakin Kevin and 9 othersDirector, 10% Owner | PPurchaseClass A Common Stock | +420.0K | $2.50 | +$1.05M | +4.6%9.52M after | |
| Oct 5, 2023 (view filing)4:43 PM ET | Sep 21, 2021 | 744 daysLate | Rakin Kevin and 9 othersDirector, 10% Owner | PPurchaseClass A Common Stock | +2.84M | – | – | +50.7%8.43M after | |
| Oct 5, 2023 (view filing)4:43 PM ET | Sep 21, 2021 | 744 daysLate | Rakin Kevin and 9 othersDirector, 10% Owner | PPurchaseClass A Common Stock | +4.26M | – | – | –4.26M after | Derivative |
| Dec 7, 2022 (view filing)4:31 PM ET | Dec 5 | 2 days | Rakin Kevin and 9 othersDirector, 10% Owner | PPurchaseClass A Common Stock | +735.0K | $4.75 | +$3.49M | +15.1%5.60M after | |
| Dec 10, 2021 (view filing)4:22 PM ET | Dec 8 | 2 days | Rakin Kevin and 9 othersDirector, 10% Owner | PPurchaseClass A Common Stock | +412.7K | $4.24 | +$1.75M | New position90.8K after | 2 lots |
QSI Quantum-Si Inc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2022 (view filing) | Dec 15 | 1 day | Rakin KevinDirector | SSaleClass A Common Stock | −89.0K | $2.15 | −$191.3K | −4.7%1.80M after |
ORMP Oramed Pharmaceuticals Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 22, 2022 (view filing) | Mar 21 | 1 day | Rakin KevinDirector | SSale | −10.0K | $9.41 | −$94.1K | −17.6%46.7K after | |
| Sep 20, 2021 (view filing) | Sep 16 | 4 days | Rakin KevinDirector | SSale | −21.1K | $20.99 | −$442.9K | −27.0%57.0K after |